CBLL
CeriBell, Inc.+$1.31 (4.86%) At close $28.27 · Today
☾After Hours −$4.47 (15.81%) Nov 3, 7:59 PM ET
About CBLL
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Company
- Headquarters
- Sunnyvale, CA
- Employees
- 300 (2026)
- Listed
- Oct 11, 2024
- Exchange
- Nasdaq
- Website
- ceribell.com
- SEC industry
- Electromedical & Electrotherapeutic Apparatus
- Cylvex sector
- Health Care · Medical Devices
Medical Devices
- Market cap #56 of 163
- P/B #36 of 152
Ranked highest first among stocks Cylvex covers.
- ABTAbbott Laboratories$189.3B-0.69%
- ISRGIntuitive Surgical Inc$155.7B+0.89%
- MDTMedtronic plc$126.5B-0.41%
- SYKStryker Corporation$119.1B+1.22%
- BSXBoston Scientific Corp.$63.04B-1.85%
Financial summary
Related companies
About
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
From company filings and market data · Not investment advice
Price data
52W range and average volume from daily bars (unadjusted, last 252 sessions).
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.